Pastorino and colleagues noted that defining cure in stage II and III colon cancer has been challenging for two reasons: It is difficult to determine the threshold at which the chances of relapse ...

APTIV HLDS LTD (APTV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...